Table 2 Baseline characteristics of the study participants
|  | Mean ± SD | Range |
|---|---|---|
Age (years) | 38.8 ± 10.5 | 21–58 |
Pulse rate (min−1) | 73.4 ± 8.4 | 59–96 |
Systolic Blood Pressure (mmHg) | 124.0 ± 10.8 | 101–139 |
Diastolic Blood Pressure (mmHg) | 76.8 ± 8.4 | 55–89 |
Height (cm) | 163.5 ± 6.4 | 152–178 |
Weight (kg) | 66.5 ± 11.5 | 41.8–89.2 |
Body Mass Index (kgm−2) | 24.8 ± 3.6 | 18.1–33.8 |
Waist circumference (cm) | 86.6 ± 10.6 | 64–111 |
Hip circumference (cm) | 97.8 ± 9.0 | 79–119 |
Waist to Hip ratio | 0.9 ± 0.1 | 0.7–1.2 |
Haemoglobin (g/dl) | 14.3 ± 1.6 | 12.2–16.2 |
White blood cell count (×109 per mm3) | 6.1 ± 0.5 | 4.8–6.9 |
Platelet count (×109 per mm3) | 202 ± 10.4 | 187–220 |
Fasting blood glucose (mg/dl) | 91.2 ± 6.9 | 80–104 |
Serum creatinine (mg/dl) | 0.9 ± 0.2 | 0.1–1.2 |
AST (U/l) | 27.9 ± 7.3 | 13–40 |
ALT (U/l) | 21.0 ± 10.9 | 5–39 |
Serum bilirubin (mg/dl) | 0.8 ± 0.4 | 0.1–1.7 |
PT/INR | 1.1 ± 0.1 | 0.8–1.2 |
Total cholesterol (mg/dl) | 226.4 ± 38.7 | 120–288 |
LDL cholesterol (mg/dl) | 152.8 ± 37.1 | 67–227 |
HDL cholesterol (mg/dl) | 52.7 ± 14.2 | 25–86 |
VLDL cholesterol (mg/dl) | 24.6 ± 15.2 | 12.5–83.4 |
Triglycerides (mg/dl) | 112.1 ± 49.9 | 42–226 |